PD(AI): the role of artificial intelligence in the management of patent ductus arteriosus

J Perinatol. 2023 Feb;43(2):257-258. doi: 10.1038/s41372-023-01606-7. Epub 2023 Jan 16.

Authors

Puneet Sharma¹, Kristyn Beam², Philip Levy³, Andrew L Beam⁴

Affiliations

¹ Division of Newborn Medicine, Boston Children's Hospital, Boston, MA, USA. puneet.sharma@childrens.harvard.edu.
² Department of Neonatology, Beth Israel Deaconess Medical Center, Boston, MA, USA.
³ Division of Newborn Medicine, Boston Children's Hospital, Boston, MA, USA.
⁴ Department of Epidemiology, Harvard T.H. Chan School of Public Health, Boston, MA, USA.

PMID: 36646822
DOI: 10.1038/s41372-023-01606-7

No abstract available

Publication types

Letter
Comment

MeSH terms

Artificial Intelligence
Ductus Arteriosus, Patent* / diagnostic imaging
Ductus Arteriosus, Patent* / therapy
Humans
Indomethacin
Infant, Newborn
Infant, Premature
Persistent Fetal Circulation Syndrome*

Substances

Indomethacin

Grants and funding

T32 HD098061/HD/NICHD NIH HHS/United States